In a new study, researchers found that cannabis-based medication can helps fight dependency on cannabis, one of the most widely used drugs globally.
The study provides the first strong evidence that cannabinoid agonist medication, which targets receptors in the brain, could reduce the rate of relapse.
The research was conducted by a team from the University of Sydney and NSW Health. In the study, the cannabis concentrate comprises equal proportions of cannabidiol (CBD) and the psychoactive tetrahydrocannabinol (THC).
It is sprayed under the tongue and avoids the health impacts linked to smoking cannabis such as respiratory issues.
To read more, click on https://knowridge.com